Biography

Robert has served as our Chief Development Officer since January 2017. Robert joined Alector from SciClone Pharmaceuticals, Inc. (acquired by a consortium led by GL Capital Partners, LLC), a biotechnology company, where he served as Senior Vice President of Product Development and Supply Chain from June 2011 to January 2017. Prior to SciClone Pharmaceuticals, Robert served as VP of Product Development and Manufacturing at biotechnology company Bayhill Therapeutics, Inc. from 2006 to 2011. Robert served as VP Product Development and Manufacturing at biotechnology company Rinat Neuroscience Corp. (acquired by Pfizer), from 2003 to 2006. Robert served in positions of increasing responsibility at COR Therapeutics, Inc. (acquired by Millennium Pharmaceuticals, Inc. in 2002) from 1993 to 2003. From 1991 to 1993, Robert served as a Scientist in the Purification and Pharmaceutical Sciences groups at California Biotechnology/Scios. From 1988 to 1991, Robert was a Scientist at Molecular Devices Corporation. Robert holds a Ph.D. in Chemical Engineering from the University of California, Berkeley, and a B.S. in Chemical Engineering from the University of Washington.